- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By 
Kyle Brasseur2023-08-29T18:23:00
A Chicago-based broker-dealer agreed to pay a $1.5 million penalty as part of a settlement with the Securities and Exchange Commission (SEC) for allegedly failing to file nearly 500 suspicious activity reports (SARs) largely related to microcap or penny stock securities transactions.
Archipelago Trading Services operates an over-the-counter (OTC) alternative trading system (ATS) for equity securities used by broker-dealers to execute trades. The SEC faulted the firm for not properly supervising high-risk securities transactions it executed daily over an eight-year span, the agency said in a press release Tuesday.
Beginning in August 2012, Archipelago operated its ATS, known as Global OTC, without a reasonably designed anti-money laundering (AML) surveillance program for its transactions, according to the SEC’s order. It wasn’t until September 2020 that the firm established proper AML policies and procedures for tracking transactions.
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
New York-based broker-dealer OTC Link will pay a $1.2 million fine to settle charges levied by the Securities and Exchange Commission over allegedly failing to implement a system to monitor and report potential suspicious activities on its platforms.
Intercontinental Exchange and nine affiliates agreed to pay $10 million for allegedly failing to inform the Securities and Exchange Commission of a cyber intrusion as required by Regulation Systems Compliance and Integrity.
New York-based broker-dealer Maxim Group agreed to pay an $800,000 fine in settling with the Securities and Exchange Commission regarding the firm’s alleged failures to file required suspicious activity reports and properly execute certain short sales.
German petrochemical parts supplier Aiotec agreed to pay $14.5 million to settle allegations that it engaged in a four-year conspiracy to dismantle and ship a plastics manufacturing plant owned by a U.S. company to Iran, in violation of U.S. sanctions.
Kiromic BioPharma will pay no fine to the Securities and Exchange Commission after self-reporting that it failed to disclose material information about two cancer drugs to investors.
The U.K. Financial Conduct Authority fined the London branch of Australian-based Macquarie Bank Limited more than 13 million pounds (U.S. $16.3 million) for “serious control failures” that allowed a trader to conceal hundreds of fictitious trades over a 20-month period.
